SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-028010
Filing Date
2021-05-14
Accepted
2021-05-14 16:06:40
Documents
79
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ibrx-10q_20210331.htm   iXBRL 10-Q 7334522
2 EX-31.1 ibrx-ex311_109.htm EX-31.1 23576
3 EX-31.2 ibrx-ex312_108.htm EX-31.2 23585
4 EX-32.1 ibrx-ex321_107.htm EX-32.1 8397
5 EX-32.2 ibrx-ex322_106.htm EX-32.2 8306
  Complete submission text file 0001564590-21-028010.txt   17612892

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA ibrx-20210331.xsd EX-101.SCH 73880
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ibrx-20210331_cal.xml EX-101.CAL 77007
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ibrx-20210331_def.xml EX-101.DEF 308269
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ibrx-20210331_lab.xml EX-101.LAB 599303
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ibrx-20210331_pre.xml EX-101.PRE 497700
11 EXTRACTED XBRL INSTANCE DOCUMENT ibrx-10q_20210331_htm.xml XML 2911619
Mailing Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121
Business Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121 (858) 633-0300
ImmunityBio, Inc. (Filer) CIK: 0001326110 (see all company filings)

IRS No.: 431979754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37507 | Film No.: 21924574
SIC: 2836 Biological Products, (No Diagnostic Substances)